Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE: 300255)

Hebei Changshan Biochemical Pharmaceutical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 26, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Market Capitalization	17,655	11,957	5,036	7,472	5,693	5,086
Market Cap Growth	-2.47%	137.41%	-32.60%	31.26%	11.92%	33.01%
Enterprise Value	19,636	14,091	6,817	8,617	6,631	5,394
Last Close Price	19.21	13.01	5.47	8.09	6.15	5.40
PE Ratio	-	-	287.58	31.99	22.51	22.58
Forward PE	-	12.44	12.44	12.44	12.44	12.44
PS Ratio	14.06	8.48	2.16	2.52	2.41	2.46
PB Ratio	9.71	6.64	1.65	2.43	2.00	1.87
P/TBV Ratio	7.96	8.02	1.80	2.68	2.20	2.00
P/FCF Ratio	124.07	-	-	-	-	-
P/OCF Ratio	39.01	354.53	1611.41	2602.11	-	-
EV/Sales Ratio	18.61	9.99	2.92	2.90	2.81	2.60
EV/EBITDA Ratio	-	-	41.33	22.68	15.64	15.09
EV/EBIT Ratio	-	-	63.13	26.59	17.98	17.68
EV/FCF Ratio	137.98	-	-	-	-	-
Debt / Equity Ratio	1.32	1.32	0.82	0.57	0.47	0.31
Debt / EBITDA Ratio	-	-	15.10	4.58	3.14	2.38
Debt / FCF Ratio	16.46	-	-	-	-	-
Asset Turnover	0.21	0.27	0.42	0.61	0.56	0.53
Inventory Turnover	0.84	0.85	0.56	0.60	0.45	0.45
Quick Ratio	0.31	0.29	0.72	0.52	0.67	0.80
Current Ratio	1.13	1.18	2.18	1.97	2.12	2.13
Return on Equity (ROE)	-39.82%	-51.43%	0.33%	7.81%	9.01%	8.48%
Return on Assets (ROA)	-11.64%	-13.46%	1.20%	4.15%	5.41%	4.90%
Return on Capital (ROIC)	-12.76%	-14.74%	1.30%	4.50%	5.94%	5.39%
Earnings Yield	-5.70%	-10.37%	0.35%	3.13%	4.44%	4.43%
FCF Yield	0.81%	-1.72%	-8.50%	-4.08%	-6.73%	-4.36%
Dividend Yield	0.00%	-	0.09%	0.32%	-	0.24%
Payout Ratio	0.00%	-	708.02%	26.50%	27.08%	31.78%
Buyback Yield / Dilution	8.98%	-4.91%	6.27%	0.23%	0.24%	-0.58%
Total Shareholder Return	8.98%	-4.91%	6.37%	0.55%	0.24%	-0.34%

Source: S&P Capital IQ. Standard template. Financial Sources.